July 24, 2012 -- Could a nasal spray provide a quick antidote to suicidal thoughts among soldiers? An Indiana University School of Medicine scientist has been awarded a $3 million research grant from the U.S. Army to develop such a system.
IU, Purdue partner to share influential nutritional data from innovative summer camp research program
July 12, 2012 -- Data that has been used for many years to set adolescent calcium intake recommendations in the U.S. and abroad are publicly open to research scientists across the globe for the first time thanks to a collaborative project between Indiana University and Purdue University supported by the Indiana Clinical and Translational Sciences Institute.
June 7, 2012 -- One of the first systematic examinations of the safety of in-hospital underwater births in the United States commences this month, when Regenstrief Institute fellow Jeanne Ballard, M.D., an obstetrician/gynecologist with more than 16 years of experience delivering babies, collaborates with Regenstrief investigator Michael Weiner, M.D., MPH to put the tools of medical informatics and outcomes research to work to improve reproductive health care.
May 10, 2012 -- Anantha Shekhar, M.D., Ph.D., associate dean for translational research and Raymond E. Houk Professor of Psychiatry and Professor of Neurobiology and Pharmacology at the Indiana University School of Medicine, has been named president of the Association for Clinical and Translational Science at the group’s annual meeting in Washington, D.C., April 18 to 20.
May 2, 2012 -- An institute established four years ago with a multimillion-dollar grant from the National Institutes of Health announced that it has distributed more than $12.5 million in grants and awards to support research since 2008 and currently supports more than 80 full-time equivalent professional jobs across Indiana.
April 12, 2012 -- Regenstrief Institute investigator Kurt Kroenke, M.D., will receive the 2012 Distinguished Educator Award, to be presented at Translational Science 2012 in Washington, D.C., April 18 to 20. Dr. Kroenke is also Chancellor's Professor of Medicine in the Indiana University School of Medicine and a research scientist with the Center of Excellence on Implementing Evidence-Based Practice at the Richard Roudebush VA Medical Center in Indianapolis.
March 28, 2012 -- The Indiana Clinical and Translational Sciences Institute Community Health Engagement Program will provide about $120,000 in small grants to seven innovative partnership projects between local community groups and researchers at Indiana University, Purdue University and the University of Notre Dame. These partnerships will focus on improving health and health care in neighborhoods across the state.
October 4, 2011 -- Hoosiers will get the chance to contribute to projects aimed at accelerating health care research in Indiana at several health events across the state in October.
September 27, 2011 -- Support from a statewide research institute centered at the Indiana University School of Medicine will expand a project to fight colorectal cancer from Indianapolis to rural and suburban communities in north central Indiana.
August 17, 2011 -- An Indiana University scientist studying human bone growth has received a $2.6 million grant from the U.S. Department of Defense to study a chemical compound with potential to fight osteoporosis and accelerate broken bone healing.
July 21, 2011 -- The Indiana Clinical and Translational Sciences Institute (CTSI) is pioneering a new technology collaboration with the Big Ten universities and the University of Chicago to facilitate access to cutting-edge online tools that ease information sharing and group work among researchers at multiple institutions.
July 14, 2011 -- The Indiana Clinical and Translational Sciences Institute will participate in the INShape Indiana Black & Minority Health Fair from July 14-17 in the Indiana Convention Center.
June 15, 2011 -- The Indiana Clinical and Translational Sciences Institute has awarded nearly $3 million to a new generation of medical students and researchers at Indiana University, Purdue University and the University of Notre Dame to encourage home-grown innovation in Indiana.
June 14, 2011 -- Mervin C. Yoder, Jr., M.D., a veteran researcher and pediatrician at the Indiana University School of Medicine, has been appointed assistant dean for entrepreneurial research at the school and an associate director of the Indiana Clinical and Translational Sciences Institute (CTSI).
March 31, 2011 -- Children's doctors in Indiana soon will partner with colleagues in Ohio and Kentucky through a new program focused on working across state lines to advance research on childhood disease.
March 2, 2011 -- An organization dedicated to improving medical innovation in Indiana is reaching out to those who want to help doctors interested in developing new and better treatments for patients throughout the state.
February 18, 2011 -- Indiana's first economic development mission to India will include the director of the Indiana Clinical and Translational Sciences Institute, Anantha Shekhar, M.D., Ph.D., who will travel to India Sunday (Feb. 20) to participate in a week-long trade mission led by Indiana Secretary of Commerce Mitch Roob. The mission will focus on establishing partnerships with information technology, life sciences and new energy companies in India.
February 17, 2011 -- The Indiana Clinical and Translational Sciences Institute is providing affiliated researchers trial access through March to the powerful research tool MetaDrug, which is made available through a CTSI-wide institutional licensing agreement with GeneGo, Inc., a Thomson Reuters Company.
January 11, 2011 -- Indiana University researchers, with support from the National Institutes of Health and the Indiana Clinical and Translational Sciences Institute, are continuing to uncover the microorganisms behind many common -- but poorly understood -- bacterial infections affecting sexually active men in Indiana.
January 6, 2011 -- A simpler form of testing individuals with risk factors for diabetes could improve diabetes prevention efforts by substantially increasing the number of individuals who complete testing and learn whether or not they are likely to develop diabetes